USPTO grants patent for Quick-Med's proprietary NIMBUS polymeric antimicrobial technology

Quick-Med Technologies, Inc. (OTCBB:QMDT), a leader in developing innovative antimicrobial technologies for the healthcare and consumer markets, today announced that it has been granted U.S. Patent No. 7,709,694 from the United States Patent and Trademark Office (USPTO). The patent for company's proprietary NIMBUS^® polymeric antimicrobial technology is applicable to a variety of base materials including woven and nonwoven fabrics. 

"This patent issuance significantly enhances the current protection for our proprietary NIMBUS technology, further validating its innovative nature," said J. Ladd Greeno, Quick-Med's CEO. "Further, the patent underscores our leadership in developing the first non-leaching antimicrobial available in a wound dressing. While other antimicrobial dressings rely on the release of chemicals into the wound bed that can impede the wound healing process, a non-leaching antimicrobial dressing represents a significant improvement."

The broad range of materials covered under the provisions of the patent include those that are composed of natural fibers, such as cotton and wool, as well as synthetics such as polyurethane, polyester, nylon and polypropylene. The applications included in the allowed claims are for a full spectrum of products such as medical devices including wound and burn dressings and blood transfer and storage products, surgical drapes and gowns, bedding, industrial and military protective wear and consumer apparel plus hygienic products such as wipes, diapers and feminine care.